DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
66	IgA腎症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02282930 (ClinicalTrials.gov)	March 2015	31/10/2014	Pilot Study of ACTH in the Treatment of Immunoglobulin A (IgA) Nephropathy at High Risk of Progression	An Open-Label Pilot Study of ACTH in the Treatment of IgA Nephropathy at High Risk of Progression	Progressive IgA Nephropathy;Proteinuria	Drug: ACTH (Acthar) Gel	Mayo Clinic	Mallinckrodt	Completed	18 Years	N/A	All	20	Phase 3	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

March 2015

31/10/2014

Pilot Study of ACTH in the Treatment of Immunoglobulin A (IgA) Nephropathy at High Risk of Progression

An Open-Label Pilot Study of ACTH in the Treatment of IgA Nephropathy at High Risk of Progression

Progressive IgA Nephropathy;Proteinuria

Drug: ACTH (Acthar) Gel

Mayo Clinic

Mallinckrodt

Completed

18 Years

N/A

All

Phase 3

United States